Corporate calendar for Abivax S.A. (ABVX): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Abivax S.A., operating as ABIVAX Société Anonyme, is a French pharmaceutical firm focused on the discovery and optimization of therapeutic drugs for inflammatory, infectious, and oncological diseases. A cornerstone of their product pipeline is ABX464, which is currently undergoing Phase IIb clinical trials for ulcerative colitis, Crohn's Disease, and COVID-19.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | $0.88 | $2.29B |
| 2026-09-15 | $379M | |
| 2026-09-15 | $1.03 | $19.67B |
| 2026-09-15 | $3M | |
| 2026-09-15 | $22M | |
| 2026-09-15 | $7M |
Price
| Price | $106.32 |
| Market Cap | $7.8B |
| Exchange | NASDAQ |
| Country | FR |
Related companies: AXSM · CORT · CYTK · HALO · JAZZ · MDGL · MRUS
Explore sector: Healthcare · Biotechnology
More sections of ABVX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks